Le Lézard
Classified in: Health
Subject: SVY

Pacemaker Devices Market to hit US$5.5 bn by 2022; North America Leads Revenue Generation, Says TMR


ALBANY, New York, November 8, 2018 /PRNewswire/ --

With several well-entrenched medical companies operating in the global pacemaker devices market, its competitive landscape is somewhat fragmented. Over the course of the next few years, the market is set to become further crowded as more specialist players enter the fray. In order to thrive in such a competitive space, players are seen focusing on product innovations and expanding geographical outreach across under tapped emerging markets.

     (Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6586

Leveraging such game plans, players that have come to hold a key position in the global pacemaker devices market are Biotronik SE & Co. KG, Boston Scientific Corporation, Medtronic Plc., OSYPKA AG, Pacetronix Limited, and Lepu Medical Technology.

A report on the global pacemaker devices market finds that it would rise at a solid CAGR of 8.1% from 2017 to 2022. At this pace, it would attain a value of US$8.1 bn by 2022 from US$5.5 bn.

Products in the global pacemaker devices market can be broadly segmented into implantable and external. Between the two, the segment of implantable pacemaker devices accounts for a dominant share in the market - in 2017 it was a substantial 65.0%. In the near term as well the implantable devices are expected to retain their key share because of more advanced products hitting the market every now and then. When it comes to geography segments, North America at present leads the global pacemaker devices market because of its advanced healthcare infrastructure and high per capita healthcare spends of its people. The North America pacemaker devices market is set to rise at 8.7% CAGR over the course of the forecast period.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6586

Higher Investments in Development of Medical Devices Bodes well for Market 

Supporting the growth of the global pacemaker devices market is the supportive regulations and increased funding towards research and development of medical devices. Both government and private bodies are seen allocating funds. All these are leading to launch of better products that accord better comfort and functionality. The surging instances of cardiovascular conditions, especially in advanced Western economies has warranted such funding from relevant authorities."

Another factor benefitting sales in the global pacemaker devices market is the incorporation of advanced connectivity features in the latest batch of pacemakers. With the emergence of technologically advanced products, the sales growth is expected to pick up further pace. Sensing an opportunity, already specialized medical device companies are jumping into the arena with specialty products.

Request for Discount on This Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=6586

Players in Pacemaker Devices Market Turn Gaze to Under-tapped Emerging Economies 

A noticeable trend in the global pacemaker devices market is the focus on upcoming markets in emerging economies by nimble players. As medical infrastructure across them strengthens, the prospects of pacemaker devices market grows too. Elaborates the lead analyst of our report, "The strong presence of advanced technology locally is helping keen players to tap into the vast growth opportunities."

Browse More Healthcare Market Research Reports

Popular Research Reports by TMR: 

  • Medical Aesthetic Devices Market (Product - Aesthetic Laser and Energy Devices, Skin Tightening and Body Contouring Devices, Aesthetic Implants, and Facial Aesthetic Devices; Application - Facial and Body Contouring, Facial and Skin Rejuvenation, Breast Enhancement, Scar Treatment, Reconstructive Surgery, Tattoo Removal, and Hair Removal): https://www.transparencymarketresearch.com/medical-aesthetics.html
  • Healthcare API Market (Services - Electronic Health Record Access, Appointments, Remote Patient Monitoring, Payment, Medical Device (Wearable); Deployment Model - On-premise, Cloud-based; End-Users - Healthcare Payers, Healthcare Providers, Patients, Vendors): https://www.transparencymarketresearch.com/healthcare-api-market.html
  • Healthcare Automation Market (Application - Therapeutic Automation, Lab and Pharmacy Automation, Logistics and Training Automation, and Diagnostics and Monitoring Automation; End Use - Pharmacies, Research institutes and labs, and Home Care): https://www.transparencymarketresearch.com/healthcare-automation-market.html

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]

Website: http://www.transparencymarketresearch.com

Research Blog: https://theglobalhealthnews.com/

SOURCE Transparency Market Research


These press releases may also interest you

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....

at 05:45
The Gross Law Firm issues the following notice to shareholders of InMode Ltd. . Shareholders who purchased shares of INMD during the...

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:20
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced that China National Medical Products Administration (NMPA) has approved the...



News published on and distributed by: